{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:31:29Z","timestamp":1786383089331,"version":"build-2736575974"},"posted":{"date-parts":[[2026,1,29]]},"group-title":"In Review","reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,20]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n Bacteriophage carry-over, the continued lytic activity of residual phages after experimental sampling, poses a significant challenge in bacteriophage research, potentially skewing experimental results, particularly in the context of preclinical studies where perceived laboratory success may not translate clinically. These inaccuracies, relevant across various bacterial species, underscore the necessity for robust mitigation strategies. This study provides an overview of strategies to mitigate phage carry-over, evaluating their performance on a combination of three mycobacteriophages with lytic activity against\n                  <italic>M. tuberculosis<\/italic>\n                  .\nResults\n We investigated three inactivation methods, including ferrous ammonium sulfate (FAS) and citrate for\n                  <italic>in vitro<\/italic>\n                  applications and N-acetyl-L-cysteine-sodium hydroxide (NALC-NaOH) for sputum decontamination. The citrate buffer offered limited and specific phage inactivation, but FAS was effective in inactivating all three mycobacteriophages (Fionnbharth\u039445\u039447, Muddy HRM\n                  <sup>N0157<\/sup>\n                  -2, and Fred313cpm-1\u039433). With pH adapted to 5.0, FAS did not significantly reduce\n                  <italic>M. tuberculosis<\/italic>\n                  H37Rv viability after five minutes exposure. Phage carry-over was determined to be phage-dependent; Fionnbharth\u039445\u039447 exhibited the most significant reduction in\n                  <italic>M. smegmatis<\/italic>\n                  colony forming units without phage inactivation measures. Furthermore, we showed that NALC-NaOH methods, commonly used for sputum decontamination, are highly effective in reducing phage titers in aqueous solutions and human sputum samples.\nConclusions\n This study demonstrates the heterogenous and phage-dependent efficacy of available inactivation buffers, underscoring the critical necessity for researchers to empirically screen their specific phage isolates against chosen inactivation methods. This is crucial to ensure that observed antibacterial effects are correctly attributed to phage activity during the experimental period, rather than to uncontrolled phage carry-over, thereby enhancing the reliability and interpretability of results.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8650511\/v1","type":"posted-content","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:16:53Z","timestamp":1769707013000},"source":"Crossref","is-referenced-by-count":0,"title":["Bacteriophage inactivation to prevent carry-over in preclinical assays with mycobacteria"],"prefix":"10.21203","author":[{"given":"Marta Pozuelo","family":"Torres","sequence":"first","affiliation":[{"name":"Radboud University Medical Centre, Radboudumc Community for Infectious Diseases & Research Institute of Medical Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Morrow","sequence":"additional","affiliation":[{"name":"TASK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Andr\u00e9s","family":"Guerrero-Bustamante","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham F.","family":"Hatfull","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Diacon","sequence":"additional","affiliation":[{"name":"TASK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko van","family":"Ingen","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre, Radboudumc Community for Infectious Diseases & Research Institute of Medical Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Janssen","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre, Radboudumc Community for Infectious Diseases & Research Institute of Medical Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Guerrero-Bustamante CA, Dedrick RM, Garlena RA, Russell DA, Hatfull GF. Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains. mBio. 2021 May 20;12(3):e00973-21. doi: 10.1128\/mBio.00973-21. PMID: 34016711; PMCID: PMC8263002.","DOI":"10.1128\/mBio.00973-21"},{"key":"ref2","unstructured":"2. World Health Organization. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. www.who.int.2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Dedrick RM, Smith BE, Cristinziano M, et al. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease. Clin Infect Dis 2023; 76: 103\u201312.","DOI":"10.1093\/cid\/ciac453"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Schmalstig AA, Wiggins A, Badillo D, Wetzel KS, Hatfull GF, Braunstein M. Bacteriophage infection and killing of intracellular Mycobacterium abscessus. mBio. 2024 Jan 16;15(1):e0292423. doi: 10.1128\/mbio.02924-23. Epub 2023 Dec 7. PMID: 38059609; PMCID: PMC10790704","DOI":"10.1128\/mbio.02924-23"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Janssen S, Larsen SE, Morrow C, Ramsubag B, Pozuelo Torres M, Guerrero Bustamante CA, et al. Preclinical Evidence for Phage Therapy to Treat Mycobacterial Infections: A Narrative Review. PHAGE. 2025 Jun 12","DOI":"10.1089\/phage.2024.0059"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother. 2010 Jan;54(1):397\u2013404. doi: 10.1128\/AAC.00669-09. Epub 2009 Oct 12. PMID: 19822702; PMCID: PMC2798481.","DOI":"10.1128\/AAC.00669-09"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Blanco-Picazo P, Fern\u00e1ndez-Orth D, Brown-Jaque M, Mir\u00f3 E, Espinal P, Rodr\u00edguez-Rubio L, Muniesa M, Navarro F. Unravelling the consequences of the bacteriophages in human samples. Sci Rep. 2020 Apr 21;10(1):6737. doi: 10.1038\/s41598-020-63432-7. PMID: 32317653; PMCID: PMC7174282.","DOI":"10.1038\/s41598-020-63432-7"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Karczewska M, Strzelecki P, Szalewska-Pa\u0142asz A, Nowicki D. How to Tackle Bacteriophages: The Review of Approaches with Mechanistic Insight. Int J Mol Sci. 2023 Feb 23;24(5):4447. doi: 10.3390\/ijms24054447. PMID: 36901878; PMCID: PMC10003480.","DOI":"10.3390\/ijms24054447"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Wiggins A, Chaudhry UN, Bisaro F, Lueck A, Schmalstig AA, Hatfull GF, Hill DB, Braunstein M. Inactivating conditions of therapeutic mycobacteriophages. bioRxiv [Preprint]. 2025 Sep 30:2025.09.30.679648. doi: 10.1101\/2025.09.30.679648. PMID: 41256447; PMCID: PMC12621657.","DOI":"10.1101\/2025.09.30.679648"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Wilson SM, al-Suwaidi Z, McNerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat Med. 1997 Apr;3(4):465-8. doi: 10.1038\/nm0497-465. PMID: 9095184.","DOI":"10.1038\/nm0497-465"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Jacobs-Sera D, Marinelli LJ, Bowman C, Broussard GW, Guerrero Bustamante C, Boyle MM, Petrova ZO, Dedrick RM, Pope WH; Science Education Alliance Phage Hunters Advancing Genomics And Evolutionary Science Sea-Phages Program; Modlin RL, Hendrix RW, Hatfull GF. On the nature of mycobacteriophage diversity and host preference. Virology. 2012 Dec 20;434(2):187\u2013201. doi: 10.1016\/j.virol.2012.09.026. Epub 2012 Oct 22. PMID: 23084079; PMCID: PMC3518647.","DOI":"10.1016\/j.virol.2012.09.026"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. White A, Knight V. Effect of tween 80 and serum on the interaction of mycobacteriophage D-29 with certain mycobacterial species. Am Rev Tuberc. 1958 Jan;77(1):134\u2009\u2212\u200945. doi: 10.1164\/artpd.1958.77.1.134. PMID: 13498299.","DOI":"10.1001\/archderm.1958.01560010136036"},{"key":"ref13","unstructured":"13. White A, Lyon L, Foster F. Effect of human serum and Tween 80 on several mycobacteriophages and susceptible mycobacteria. Am Rev Respir Dis. 1963 May;87:730-3. doi: 10.1164\/arrd.1963.87.5.730. PMID: 14000279."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Heller DM, Viknesh Sivanathan, Asai DJ, Hatfull GF. SEA-PHAGES and SEA-GENES: Advancing Virology and Science Education. Annual Review of Virology. 2024 Apr 29;11(1).","DOI":"10.1146\/annurev-virology-113023-110757"},{"key":"ref15","unstructured":"15. The Actinobacteriophage Database | Manufacturing a High Titer Lysate. Procedures and Protocols. Phagesdb.org. 2019. https:\/\/phagesdb.org\/workflow\/"},{"key":"ref16","unstructured":"16. The Actinobacteriophage Database | Titering. Procedures and Protocols. Phagesdb.org. 2019. Available from: https:\/\/phagesdb.org\/workflow\/"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. McNerney R, Wilson SM, Sidhu AM, Harley VS, al Suwaidi Z, Nye PM, Parish T, Stoker NG. Inactivation of mycobacteriophage D29 using ferrous ammonium sulfate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res Microbiol. 1998 Jul-Aug;149(7):487\u2009\u2212\u200995. doi: 10.1016\/s0923-2508(98)80003-x. PMID: 9766200.","DOI":"10.1016\/S0923-2508(98)80003-X"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Hu L, Page MA, Sigstam T, Kohn T, Mari\u00f1as BJ, Strathmann TJ. Inactivation of bacteriophage MS2 with potassium ferrate(VI). Environ Sci Technol. 2012 Nov 6;46(21):12079-87. doi: 10.1021\/es3031962. Epub 2012 Oct 16. PMID: 23030462.","DOI":"10.1021\/es3031962"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Baker JJ, Dechow SJ, Abramovitch RB. Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH. Trends Microbiol. 2019 Nov;27(11):942\u2013953. doi: 10.1016\/j.tim.2019.06.005. Epub 2019 Jul 16. PMID: 31324436; PMCID: PMC6800632.","DOI":"10.1016\/j.tim.2019.06.005"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8650511\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8650511\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T17:08:34Z","timestamp":1786381714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8650511\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8650511\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12866-026-05431-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,29]]},"subtype":"preprint"}}